ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO339

Cardiac Implantable Electronic Device Infections in Patients with Renal Insufficiency: A Meta-Analysis

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Chandramohan, Deepak, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Simhadri, Prathap, AdventHealth, Altamonte Springs, Florida, United States
  • Singh, Prabhat, Christus Spohn Health System, Corpus Christi, Texas, United States
  • Garapati, Hari Naga, Baptist Medical Center East, Montgomery, Alabama, United States
  • Konda, Raghunandan, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Chandramohan, Divya, The University of Texas at San Antonio, San Antonio, Texas, United States
  • Jena, Nihar K., Trinity Health Oakland Hospital, Pontiac, Michigan, United States
  • Naik, Roopa, Geisinger Health, Danville, Pennsylvania, United States
Background

Renal insufficiency is a risk factor for cardiac implantable electronic device (CIED) infection.

Methods

To identify studies, we conducted a comprehensive search of multiple electronic databases. Using the random effects model, we calculated the pooled rates and odds ratios. We utilized the Cochran Q and I2 statistics to detect heterogeneity.

Results

A total of 17 studies comprising 263,819 chronic kidney disease (CKD) and 89,617 end stage renal disease (ESRD) patients were included. The mean age was 68.6 years (95% CI: 66.4-70.8; I2: 99.7). The pooled rate of CIED infection in patients with CKD was 4.3% (95% CI: 2-8.8; I2: 95.7) and ESRD was 5.9% (95% CI: 3.3-10.5; I2: 99.3). The pooled risk of CIED infection in the CKD population was OR 2.5 (95% CI: 1.9-3.3; p <0.001; I2: 21.1), and in ESRD was OR 2.4 (95% CI: 1.01-5.7; p = 0.046; I2: 88.8). ESRD was associated with higher mortality, OR 2.5 (95% CI: 1.4-4.4.8; p = 0.001; I2: 95).

Conclusion

The rates of CIED infections in renal insufficiency are significant. CKD and ESRD are associated with an increased risk of infection. ESRD patients have an increased risk of mortality.